SAN FRANCISCO Noubar Afeyan, one of biotechs top investors, warned in an annual letter that a backlash against science in the U.S. could endanger U.S. life expectancy, take a sledgehammer to biotech … [+934 chars]
No comments yet. Be the first to comment!